Factor V Level at Test Zone Diagnostic Center

Understanding the Factor V Level at Test Zone Diagnostic Center

The Factor V Level test is a highly specialized coagulation assay designed to measure the activity and concentration of Factor V (also known as proaccelerin) in the blood plasma. Factor V is an essential protein synthesized primarily by the hepatocytes in the liver. It plays a critical role in the human coagulation cascade, specifically acting as a non-enzymatic cofactor in the common pathway. Within this pathway, activated Factor V (Factor Va) binds with activated Factor X (Factor Xa), calcium ions, and phospholipid surfaces to form the prothrombinase complex. This complex is responsible for the rapid conversion of prothrombin (Factor II) into thrombin (Factor IIa), which subsequently converts soluble fibrinogen into insoluble fibrin strands, forming a stable blood clot. A deficiency or dysfunction in Factor V can severely impair thrombin generation, leading to a significant bleeding diathesis, whereas certain genetic mutations can lead to resistance to inactivation, causing a hypercoagulable state.

At Test Zone Diagnostic Center, the Factor V Level assay is performed using state-of-the-art automated coagulation analyzers that utilize advanced photo-optical or mechanical clot detection technologies. By precisely measuring the time it takes for a patient’s plasma to clot after the addition of specific reagents, our clinical laboratory provides highly accurate quantitative assessments of Factor V activity. This test is of paramount clinical importance when investigating patients with unexplained bleeding episodes, prolonged screening coagulation profiles, or suspected hereditary or acquired bleeding disorders. Understanding the quantitative level of Factor V allows hematologists and primary care physicians to make informed decisions regarding patient care, pre-operative risk assessment, and therapeutic interventions.

Evaluating Factor V levels is also a powerful diagnostic tool for differentiating between complex clinical conditions. For instance, because Factor V is synthesized in the liver but does not require Vitamin K for its post-translational modification, measuring its level alongside Vitamin K-dependent factors (such as Factors II, VII, IX, and X) helps clinicians distinguish between severe hepatic parenchymal disease and Vitamin K deficiency. In patients with liver failure, Factor V levels drop significantly, reflecting the liver’s diminished synthetic capacity, whereas in isolated Vitamin K deficiency, Factor V levels remain entirely normal. The diagnostic value of this assay extends to the evaluation of consumptive coagulopathies like Disseminated Intravascular Coagulation (DIC) and the identification of rare acquired Factor V inhibitors, which can arise post-operatively, after exposure to bovine thrombin, or in association with autoimmune diseases.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is vital to ensure the accuracy and reliability of coagulation assays like the Factor V Level test. Patients undergoing this evaluation at Test Zone Diagnostic Center should adhere to the following guidelines:

• Medication Disclosure: It is imperative to inform your prescribing physician and the laboratory staff of all medications you are currently taking. Anticoagulants such as heparin, warfarin (Coumadin), and direct oral anticoagulants (DOACs) like rivaroxaban, apixaban, or dabigatran can significantly interfere with clot-based coagulation assays, potentially causing falsely low Factor V activity results.
• Fasting Requirements: While strict fasting is generally not mandatory for a Factor V Level test, a light fast of 2 to 4 hours prior to sample collection is recommended to prevent lipemia. Lipemic blood samples (high fat content in the blood) can interfere with the photo-optical detection systems used in automated coagulation analyzers.
• Hydration: Maintaining adequate hydration by drinking plenty of water is encouraged, as it facilitates easier venipuncture and ensures a smooth blood draw.
• Avoid Strenuous Exercise: Patients should avoid vigorous physical exertion immediately before the test, as intense exercise can transiently elevate certain coagulation factors and alter baseline physiological clotting activity.
• Clinical History: Provide a brief medical history regarding any recent bleeding episodes, blood transfusions, surgeries, or family history of bleeding disorders to help the pathologist interpret the findings accurately.

During the Procedure

The collection of a blood sample for a Factor V Level assay is a routine venipuncture procedure performed by our highly trained phlebotomists at Test Zone Diagnostic Center. The process is conducted under strict aseptic conditions to ensure patient safety and sample integrity:

• Patient Positioning: The patient is comfortably seated, and the arm is positioned on a stable support. The phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa.
• Aseptic Preparation: The skin over the selected vein is thoroughly cleansed with an antiseptic solution (such as 70% isopropyl alcohol) and allowed to air dry completely to prevent hemolysis or contamination.
• Venipuncture and Tube Selection: A sterile, single-use needle is inserted into the vein. The blood is collected directly into a light blue-top tube containing 3.2% buffered sodium citrate. The sodium citrate acts as a reversible anticoagulant by chelating calcium ions, preserving the coagulation factors in an inactive state until testing begins.
• Critical Draw Volume: The phlebotomist ensures that the tube is filled precisely to the designated fill line. A precise 9:1 ratio of blood to sodium citrate anticoagulant is absolutely critical; underfilled or overfilled tubes alter the calcium concentration during the laboratory assay, leading to highly inaccurate and clinically invalid clotting times.
• Inversion and Mixing: Immediately after drawing, the tube is gently inverted 3 to 4 times to mix the blood thoroughly with the sodium citrate. Vigorous shaking is strictly avoided to prevent mechanical hemolysis and premature platelet activation.
• Sample Transport and Processing: The sample is promptly delivered to our clinical laboratory. It undergoes centrifugation at a specific speed and duration (typically 1500g for 15 minutes) to obtain platelet-poor plasma (PPP). The plasma is then analyzed immediately or frozen at ultra-low temperatures if testing is delayed, preserving the labile Factor V protein.

When is a Factor V Level Performed?

Investigating Unexplained Bleeding Disorders

Physicians frequently request a Factor V Level test when a patient presents with unexplained, recurrent, or prolonged bleeding episodes. These symptoms may manifest as frequent epistaxis (nosebleeds), easy bruising (ecchymosis) without significant trauma, prolonged bleeding from minor cuts, or unusually heavy and prolonged menstrual bleeding (menorrhagia). By quantifying the activity of Factor V, hematologists can determine if a deficiency in this specific cofactor is the underlying cause of the impaired hemostasis, allowing for targeted therapeutic planning, such as the administration of fresh frozen plasma (FFP) or specific factor concentrates during bleeding crises.

Evaluating Abnormal Coagulation Screening Tests

An abnormal result on routine screening tests, such as a prolonged Prothrombin Time (PT) and a prolonged Activated Partial Thromboplastin Time (aPTT), is a primary clinical indication for a Factor V Level assay. Because Factor V operates within the common pathway of the coagulation cascade, a deficiency in this factor will prolong both the PT and aPTT. When a mixing study (combining patient plasma with normal plasma) corrects the prolonged times, it indicates a factor deficiency rather than an inhibitor. A subsequent Factor V Level test is performed to pinpoint whether Factor V is the specific deficient protein responsible for the abnormal screening profile.

Assessing Liver Synthetic Function and Disease Severity

Since the liver is the sole site of Factor V synthesis, measuring its blood level serves as a highly sensitive marker of hepatic synthetic function. Gastroenterologists and hepatologists utilize this test to assess the severity of parenchymal liver diseases, including acute liver failure, decompensated cirrhosis, and toxic hepatitis. Because Factor V has a relatively short half-life (approximately 12 to 15 hours) compared to other liver-synthesized proteins like albumin, a decline in Factor V levels provides a real-time, highly sensitive reflection of acute hepatic injury and synthetic decline, aiding in the prognostic evaluation of patients awaiting liver transplantation.

Diagnosing Disseminated Intravascular Coagulation (DIC)

Disseminated Intravascular Coagulation (DIC) is a life-threatening, systemic clinico-pathological syndrome characterized by widespread microvascular thrombosis and subsequent consumptive coagulopathy. During the hyperactive clotting phase of DIC, coagulation factors, including Factor V, are rapidly consumed faster than the liver can synthesize them. This leads to a profound depletion of clotting factors and a high risk of catastrophic hemorrhage. A Factor V Level test, performed alongside platelet counts, fibrinogen levels, and D-dimer assays, helps clinicians monitor the severity of factor consumption and guide supportive replacement therapies.

Pre-Operative Evaluation in Patients with a Family History of Coagulopathy

Prior to undergoing major surgical procedures or invasive dental interventions, patients with a known family history of bleeding disorders or those who have experienced unexpected bleeding during previous procedures require a comprehensive pre-operative coagulation workup. Performing a Factor V Level test ensures that any mild or subclinical hereditary Factor V deficiency is identified beforehand. This proactive diagnostic approach allows surgical teams to prepare appropriate hematological support, minimize the risk of intraoperative and postoperative hemorrhage, and establish safe surgical protocols.

What Does a Factor V Level Detect?

The Factor V Level assay is highly sensitive to changes in the coagulation cascade and can detect a wide range of congenital, acquired, and physiological conditions. Clinically relevant findings and scenarios detected by this test include:

• Congenital Factor V Deficiency: Also known as Owren’s disease or parahemophilia, this rare autosomal recessive disorder is characterized by a lifelong deficiency of Factor V, leading to mild-to-severe bleeding tendencies depending on the residual factor activity.
• Severe Liver Dysfunction: Detects a reduction in hepatic synthetic capacity due to cirrhosis, acute viral hepatitis, alcoholic liver disease, or drug-induced liver injury.
• Disseminated Intravascular Coagulation (DIC): Identifies the profound consumption of Factor V during active, systemic intravascular clotting processes.
• Acquired Factor V Inhibitors: Detects the presence of neutralizing autoantibodies directed against Factor V, which can occur spontaneously, post-operatively, or after exposure to topical bovine thrombin preparations.
• Dilutional Coagulopathy: Identifies low Factor V levels resulting from massive blood transfusions or fluid resuscitation where red blood cells and crystalloids are replaced without adequate clotting factor replacement.
• Distinction from Vitamin K Deficiency: Confirms that a bleeding disorder is not related to Vitamin K deficiency, as Factor V levels remain normal in Vitamin K deficient states while Factors II, VII, IX, and X are reduced.
• Primary Fibrinolysis: Detects the degradation and depletion of Factor V by excessive circulating plasmin in rare hyperfibrinolytic states.
• Normal Coagulation Status: Verifies healthy, physiological levels of Factor V activity (typically between 50% and 150%), indicating adequate cofactor function.
• Mild Factor V Deficiency: Identifies patients with 20% to 50% factor activity, who are usually asymptomatic but may bleed excessively during major trauma or surgery.
• Moderate Factor V Deficiency: Detects activity levels between 10% and 20%, often associated with easy bruising and post-traumatic bleeding.
• Severe Factor V Deficiency: Identifies critical levels below 10% of normal activity, presenting with severe, spontaneous mucosal, joint, or soft-tissue hemorrhages.
• Acute Phase Reactant Elevation: Detects transiently elevated Factor V levels, which can occur during acute inflammation, tissue injury, or pregnancy.
• Myeloproliferative Neoplasms: Identifies secondary alterations in coagulation factor levels occasionally seen in patients with essential thrombocythemia or polycythemia vera.
• Amyloidosis-Associated Deficiency: Detects rare cases where amyloid fibrils adsorb coagulation factors, leading to acquired Factor V deficiency.
• Neonatal Coagulation Status: Helps establish baseline factor levels in newborns, who naturally have different physiological ranges of coagulation proteins compared to adults.
• Inhibitor vs. Deficiency Differentiation: When combined with mixing studies, helps differentiate between a quantitative lack of the Factor V protein and the presence of an active inhibitor.
• Post-Hepatectomy Recovery: Monitors the recovery of liver synthetic function following partial liver resection.
• Autoimmune-Related Coagulopathy: Detects factor depletion associated with systemic lupus erythematosus (SLE) or other autoimmune conditions.
• Pre-Eclampsia Coagulation Changes: Identifies alterations in clotting factor consumption in pregnant patients experiencing severe pre-eclampsia.
• Spurious Low Levels: Detects pre-analytical errors such as sample clotting in the collection tube, which consumes Factor V before the assay is run.

Turnaround Time and Report Access at Test Zone Diagnostic Center

At Test Zone Diagnostic Center, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The Factor V Level test is a specialized hematological assay that requires precise laboratory handling, centrifugation, and automated analysis. Typically, the turnaround time for a Factor V Level report is within 24 to 48 hours from the time of sample collection. Our laboratory operates under strict quality control measures to ensure that every sample is processed efficiently without compromising clinical accuracy.

Once the analysis is complete, the report is reviewed and signed off by our consultant pathologist. Patients and their referring physicians can access the diagnostic reports conveniently through multiple channels. Test Zone Diagnostic Center offers an online patient portal where reports can be viewed and downloaded securely from any smartphone or computer. Additionally, automated SMS notifications are sent to patients as soon as their reports are ready. Physical copies of the reports can also be collected directly from our main reception desk or designated collection centers.

Factor V Level Findings Overview

The following table outlines the clinical interpretation of various Factor V activity levels and their corresponding clinical implications:

Structure / Parameter Evaluated Normal Findings Possible Abnormal Findings Factor V Activity Percentage 50% to 150% of normal activity Decreased activity (< 50%) or elevated activity (> 150%) Congenital Deficiency Assessment No hereditary deficiency; normal clotting cascade function < 10% activity indicates severe congenital deficiency (Owren’s disease) Hepatic Synthetic Function Normal liver synthesis; Factor V levels within reference range Significantly decreased levels indicating acute liver failure or advanced cirrhosis Consumptive Coagulopathy (DIC) Stable factor levels; no active systemic consumption Markedly decreased Factor V levels due to rapid consumption in active DIC Vitamin K Status Differentiation Normal Factor V levels even if Vitamin K-dependent factors are low Concurrently low Factor V and Vitamin K-dependent factors point to liver disease, not isolated Vitamin K deficiency Presence of Specific Inhibitors No neutralizing antibodies or inhibitors detected in plasma Decreased Factor V activity that does not correct upon mixing with normal plasma, indicating an inhibitor Pre-operative Bleeding Risk Low risk of unexpected surgical bleeding related to Factor V Mild to moderate deficiency (10% – 50%) indicating a potential risk of post-operative hemorrhage

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Test Zone Diagnostic Center for Factor V Level?

• Experienced Healthcare Professionals: Our pathology laboratory is staffed by highly qualified consultant pathologists, hematologists, and skilled laboratory technologists specializing in complex coagulation disorders.
• Patient-Focused Care: We prioritize patient comfort and safety, ensuring a compassionate, stress-free environment during the sample collection process.
• Quality Diagnostic Services: Test Zone Diagnostic Center adheres to rigorous internal and external quality assurance programs to guarantee the highest standards of diagnostic accuracy.
• Professional Reporting: Our reports are comprehensive, clear, and structured to provide referring physicians with the precise clinical data needed for accurate diagnosis and treatment planning.
• Modern Diagnostic Approach: We utilize state-of-the-art automated coagulation analyzers and advanced laboratory methodologies to perform specialized assays.
• Comfortable Environment: Our diagnostic facilities are designed to be clean, hygienic, and welcoming, ensuring a pleasant experience for all patients.
• Convenient Location: Strategically located with easy accessibility, making it convenient for patients to visit for sample collection and report retrieval.
• Commitment to Accurate Diagnosis: We are dedicated to delivering reliable, evidence-based diagnostic insights that form the foundation of effective medical care.